AQR Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,720
| Closed | -$1.28M | – | 2334 |
|
|
2022
Q3 | $1.28M | Buy |
+18,720
| New | +$1.28M | ﹤0.01% | 1412 |
|
|
2022
Q1 | – | Sell |
-7,091
| Closed | -$208K | – | 2329 |
|
|
2021
Q4 | $208K | Buy |
+7,091
| New | +$208K | ﹤0.01% | 2081 |
|
|
2021
Q3 | – | Sell |
-13,080
| Closed | -$428K | – | 2371 |
|
|
2021
Q2 | $428K | Buy |
13,080
+7,396
| +130% | +$242K | ﹤0.01% | 1952 |
|
|
2021
Q1 | $232K | Sell |
5,684
-629
| -10% | -$25.7K | ﹤0.01% | 2074 |
|
|
2020
Q4 | $271K | Buy |
6,313
+339
| +6% | +$14.6K | ﹤0.01% | 2001 |
|
|
2020
Q3 | $326K | Sell |
5,974
-29,370
| -83% | -$1.6M | ﹤0.01% | 1880 |
|
|
2020
Q2 | $2.23M | Sell |
35,344
-3,255
| -8% | -$205K | ﹤0.01% | 1109 |
|
|
2020
Q1 | $1.97M | Buy |
38,599
+18,596
| +93% | +$950K | ﹤0.01% | 1074 |
|
|
2019
Q4 | $1.59M | Buy |
20,003
+4,360
| +28% | +$347K | ﹤0.01% | 1354 |
|
|
2019
Q3 | $759K | Buy |
15,643
+3,836
| +32% | +$186K | ﹤0.01% | 1605 |
|
|
2019
Q2 | $621K | Buy |
+11,807
| New | +$621K | ﹤0.01% | 1657 |
|
|
2019
Q1 | – | Sell |
-8,390
| Closed | -$344K | – | 2243 |
|
|
2018
Q4 | $344K | Sell |
8,390
-11,416
| -58% | -$468K | ﹤0.01% | 1918 |
|
|
2018
Q3 | $753K | Buy |
19,806
+698
| +4% | +$26.5K | ﹤0.01% | 1812 |
|
|
2018
Q2 | $864K | Sell |
19,108
-7,855
| -29% | -$355K | ﹤0.01% | 1778 |
|
|
2018
Q1 | $1.3M | Buy |
26,963
+5,487
| +26% | +$265K | ﹤0.01% | 1560 |
|
|
2017
Q4 | $845K | Buy |
21,476
+4,362
| +25% | +$172K | ﹤0.01% | 1731 |
|
|
2017
Q3 | $531K | Buy |
17,114
+2,791
| +19% | +$86.6K | ﹤0.01% | 1919 |
|
|
2017
Q2 | $392K | Buy |
14,323
+8,881
| +163% | +$243K | ﹤0.01% | 1971 |
|
|
2017
Q1 | $201K | Buy |
+5,442
| New | +$201K | ﹤0.01% | 2113 |
|